Report Highlights
The global market for biliary stents should grow from $157.9 million in 2020 to $203.1 million by 2025 with a compound annual growth rate (CAGR) of 5.2% for the period of 2020-2025.
Report Includes
- 22 data tables and 41 additional tables
- A brief overview of the global markets for biliary stents within the medical devices industry
- Analyses of the global market trends, with corresponding market analysis data for 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Estimation of the current and potential market size for biliary stents, market forecast and market share analysis on the basis of material type and geographical region
- Country specific data and analysis of the United States, Canada, Mexico, France, Germany, Italy, Spain, UK, Japan, China, India, Australia, South Korea and other emerging economies
- Insight into the factors driving and restraining the growth of global biliary stents market, along with market overviews covering manufacturing process, value chain process and pricing analysis
- Competitive landscape and key marketing strategies in biliary stents marketplace, including mergers and acquisition deals, partnerships, agreements, collaborations and joint ventures
- Detailed company profiles of major market players, including Abbott, Boston Scientific, Medtronic plc, Edward Lifesciences, CONMED and Changzhou Health Microport Medical Devices
Report Scope
This report covers a range of products, some of which are disease-specific and others that are more often used across all types of patients and in general for health management. The market for biliary stents referred to in the report is limited to the devices/products included in this report.
The study will enable its readers to understand and gain insights into the current market, and it will also forecast the changing market scenario. The data provided can help industry players understand which market segments (products) are expected to grow at higher rates, which factors are driving growth, which factors are limiting growth, what the key opportunity areas are and so on.
Discussion and analysis cover the following market factors:
- Key market analysis.
- Market dynamics (trends, drivers and restraints).
- Market forecast period of 2020 through 2025.
- Competitive developments and landscape.
- Geographic regional analysis.
- Regulatory scenario in major countries and regions
The report also provides a detailed competitive outlook, including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Medtronic plc, Cook Medical, C. R. Bard (subsidiary of BD), Abbott, Boston Scientific, Edward Lifesciences, CONMED, Taewong Medical, Allium Medical Solutions, Changzhou Health Microport Medical Devices, Dispomedica, Innovex Medical, Medinol, Merit Medical Systems, Medi-Globe, OptiMed, M.I Tech, Endotec Oy, Meditek Systems, ELLA - CS, s.r.o., Endocor GMBH, ENDOTECH, Leufen Medical, and Luda Medica, etc.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Alzheimer's Disease Therapeutics and Diagnostics: Global Markets (PHM062E)
- Impact Modifiers: Global Markets (AVM252A)
- Adhesives and Adhesive-Applying Equipment: Technologies and Global Markets (CHM073E)
- Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
- Metal-organic Frameworks: Global Markets (AVM200B)
Related Reports
Stents: Technologies and Global Markets
The global market for stents is estimated to increase from $7.8 billion in 2022 to $9.7 billion by 2027, at a compound annual growth rate (CAGR) of 4.3% during the forecast period of 2022 through 2027.
Biodegradable Stents: Global Markets
The global market for biodegradable stents should grow from $106.7 million in 2018 to $378.0 million by 2023 with a compound annual growth rate (CAGR) of 28.8% for the period of 2018-2023.
Recent Reports
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Direct-to-Consumer Genetic Testing: Global Markets and Technologies
The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.
Global Medical Tapes Market
The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More